MTP

Dược Medipharco ·UPCOM ·2024

▲ Showing improvement

Price
13,500
Latest close
03 Jun 2026
P/E
P/B
EPS
BVPS
ROE 16.8%
ROA 3.0%
Profit Margin 1.4%
Asset Turnover 2.15x
Equity Mult. 5.63x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a Năm 2024 basis, MTP is showing some signs of improvement versus the same period, but the current picture is not yet broad enough to confirm a stronger trend — profit is at an all-time high. The point still to be proven is whether this improvement broadens out in coming periods.

TTM REVENUE
VND 1,287bn
+3.3%YoY
NET MARGIN
1.38%
+0.1ppYoY
TTM NET PROFIT
VND 18bn
+11.1%YoY

Quarterly snapshot data is not available yet.

Financial Highlights

Detailed analysis of each financial dimension

Is the profit sustainable?

Margins are broadly flat — earnings quality is the factor to watch.

very positive positive stable watch under pressure

What is driving the margin?

Track net margin changes and the operating components against the same period last year.

Profitability trend

Net Margin 1.38% +0.1pp
Gross Margin
SG&A / Revenue

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Balance Sheet

Focus on inventory, liability structure, and year-end cash balance.

Inventory ended the period at 94.5bn, roughly 15.1% of total assets.

Over the last 12 months, working capital released 0.0bn of cash.

Working Capital Drivers

TTM YoY · Prior -> TTM

Receivables were broadly stable → neutral CFO:
Inventories were broadly stable → neutral CFO:
Payables were broadly stable → neutral CFO:

Working Capital Efficiency

Track receivable, inventory, and payable turns to judge working-capital efficiency.

Track DSO, DIO, DPO components to evaluate working capital turnover efficiency.

Working Capital Efficiency

TTM YoY · Prior -> TTM

Receivables
Inventory
Payables
Cash Conversion Cycle

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Statement Data

Item 2024 2023 2022
Net Revenue
1,286.9 1,245.8 1,328.5
Cost of Goods Sold
1,185.4 1,155.3 1,234.9
Gross Profit
101.5 90.5 93.6
Financial Expenses
25.3 28.9 26.6
Selling Expenses
25.3 20.1 20.9
General and Administrative Expenses
32.6 23.4 27.8
Operating Profit
21.4 20.0 19.8
Profit Before Tax
21.6 20.1 15.9
Net Income
17.8 16.0 4.6
Profit Attributable to Parent
17.8 16.0 4.6
Earnings per Share
2,390.00 2,150.00 612.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.